Found: 27
Select item for more details and to access through your institution.
Higher Risk, Higher Reward? Self‐Reported Effects of Real‐World Cannabis Use in Parkinson's Disease.
- Published in:
- Movement Disorders Clinical Practice, 2022, v. 9, n. 3, p. 340, doi. 10.1002/mdc3.13414
- By:
- Publication type:
- Article
Clinimetric Properties of the Fragile X‐associated Tremor Ataxia Syndrome Rating Scale.
- Published in:
- Movement Disorders Clinical Practice, 2019, v. 6, n. 2, p. 120, doi. 10.1002/mdc3.12708
- By:
- Publication type:
- Article
Penetrance of the Fragile X-Associated Tremor/Ataxia Syndrome in a Premutation Carrier Population.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 291, n. 4, p. 460, doi. 10.1001/jama.291.4.460
- By:
- Publication type:
- Article
Clinical Phenotype of Adult Fragile X Gray Zone Allele Carriers: a Case Series.
- Published in:
- Cerebellum, 2016, v. 15, n. 5, p. 623, doi. 10.1007/s12311-016-0809-6
- By:
- Publication type:
- Article
A Review of the Current Evidence Connecting Seborrheic Dermatitis and Parkinson's Disease and the Potential Role of Oral Cannabinoids.
- Published in:
- Dermatology (10188665), 2021, v. 237, n. 6, p. 872, doi. 10.1159/000512189
- By:
- Publication type:
- Article
Do patients with Parkinson’s disease benefit from embryonic dopamine cell transplantation?
- Published in:
- Journal of Neurology, 2003, v. 250, p. iii44, doi. 10.1007/s00415-003-1308-5
- By:
- Publication type:
- Article
Simultaneous Quantification of 17 Cannabinoids by LC–MS-MS in Human Plasma.
- Published in:
- Journal of Analytical Toxicology, 2022, v. 46, n. 4, p. 383, doi. 10.1093/jat/bkab030
- By:
- Publication type:
- Article
Aging in fragile X syndrome.
- Published in:
- Journal of Neurodevelopmental Disorders, 2010, v. 2, n. 2, p. 70, doi. 10.1007/s11689-010-9047-2
- By:
- Publication type:
- Article
Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study.
- Published in:
- JAMA Neurology, 2016, v. 73, n. 3, p. 321, doi. 10.1001/jamaneurol.2015.4265
- By:
- Publication type:
- Article
Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS).
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0225191
- By:
- Publication type:
- Article
Fibromyalgia in fragile X mental retardation 1 gene premutation carriers.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Fibromyalgia in fragile X mental retardation 1 gene premutation carriers.
- Published in:
- Rheumatology, 2011, v. 50, n. 12, p. 2233, doi. 10.1093/rheumatology/ker273
- By:
- Publication type:
- Article
Fragile X-associated tremor ataxia syndrome rating scale: Revision and content validity using a mixed method approach.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.977380
- By:
- Publication type:
- Article
Tremor and ataxia in fragile X premutation carriers: Blinded videotape study.
- Published in:
- Annals of Neurology, 2003, v. 53, n. 5, p. 616
- By:
- Publication type:
- Article
Short‐Term Cannabidiol with Δ‐9‐Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial.
- Published in:
- Movement Disorders, 2024, v. 39, n. 5, p. 863, doi. 10.1002/mds.29768
- By:
- Publication type:
- Article
Reply to: Cognitive Safety of Cannabis Products in Parkinson's Disease: Need for Solid Scientific Evidence to Guide Clinicians and Patients Currently on Shaky Grounds.
- Published in:
- Movement Disorders, 2024, v. 39, n. 1, p. 222, doi. 10.1002/mds.29667
- By:
- Publication type:
- Article
Cognitive Safety Data from a Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled Phase IIb Study of the Effects of a Cannabidiol and Δ9‐Tetrahydrocannabinol Drug on Parkinson's Disease‐Related Motor Symptoms.
- Published in:
- Movement Disorders, 2023, v. 38, n. 7, p. 1341, doi. 10.1002/mds.29447
- By:
- Publication type:
- Article
Age- and CGG repeat-related slowing of manual movement in fragile X carriers: A prodrome of fragile X-associated tremor ataxia syndrome?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Levodopa modulates small-world architecture of functional brain networks in Parkinson's disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Fragile X-Associated tremor ataxia syndrome in FMR1 gray zone allele carriers.
- Published in:
- Movement Disorders, 2012, v. 27, n. 2, p. 297, doi. 10.1002/mds.24021
- By:
- Publication type:
- Article
FMR1 gray-zone alleles: Association with Parkinson's disease in women?
- Published in:
- Movement Disorders, 2011, v. 26, n. 10, p. 1900, doi. 10.1002/mds.23755
- By:
- Publication type:
- Article
Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Impairment of executive cognitive functioning in males with fragile X-associated tremor/ataxia syndrome.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Progression of tremor and ataxia in male carriers of the FMR1 premutation.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome.
- Published in:
- Movement Disorders, 2006, v. 21, n. 10, p. 1741, doi. 10.1002/mds.21001
- By:
- Publication type:
- Article
Tremor/Ataxia syndrome in fragile X carrier males.
- Published in:
- Movement Disorders, 2002, v. 17, n. 4, p. 744, doi. 10.1002/mds.10208
- By:
- Publication type:
- Article
Functional status of men with the fragile X premutation, with and without the tremor/ataxia syndrome (FXTAS).
- Published in:
- International Journal of Geriatric Psychiatry, 2009, v. 24, n. 10, p. 1101, doi. 10.1002/gps.2231
- By:
- Publication type:
- Article